These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15604583)

  • 1. CA19-9 as a serum marker for poor prognosis in urothelial carcinoma.
    Suzuki K
    Urol Int; 2004; 73(4):357. PubMed ID: 15604583
    [No Abstract]   [Full Text] [Related]  

  • 2. CA19-9 as a serum marker for poor prognosis in urothelial carcinoma.
    Sashide K; Isobe H; Wakumoto Y; Hanazawa K; Fujita K; Fujime M
    Urol Int; 2004; 72(2):112-7. PubMed ID: 14963350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Serum CA19-9 Concentration Indicates High Chemosensitivity and Better Survival in Advanced Urothelial Carcinoma.
    Yaegashi H; Izumi K; Kadomoto S; Naito R; Makino T; Iwamoto H; Nohara T; Shigehara K; Kadono Y; Mizokami A
    Anticancer Res; 2019 Jan; 39(1):375-380. PubMed ID: 30591483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of CA19-9 producing transitional cell carcinoma of the ureter].
    Yamamoto H; Ueda Y; Maruyama T; Kondou N; Nojima M; Takiuchi H; Mori Y; Shima H; Kubota A
    Hinyokika Kiyo; 2003 Sep; 49(9):543-5. PubMed ID: 14598694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of transitional cell carcinoma of the urinary bladder with high serum level of CEA and CA19-9].
    Inai H; Shimazui T; Yamamoto T; Yamauchi A; Uchida K; Takeshima H; Akaza H
    Hinyokika Kiyo; 2001 Aug; 47(8):583-6. PubMed ID: 11579601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of transitional cell carcinoma of renal pelvis with extremely high serum levels of CA19-9 and CEA].
    Sugaya Y; Ochi M; Hashimoto S; Muraki J; Morita T; Kobayashi Y; Nakamura S; Tokue A
    Hinyokika Kiyo; 1997 Jul; 43(7):495-9. PubMed ID: 9282296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Ureteral cancer producing carbohydrate antigen 19-9: report of a case].
    Segawa N; Yamamoto K; Watsuji T; Suzuki T; Ueda H; Katsuoka Y
    Hinyokika Kiyo; 1997 Sep; 43(9):665-8. PubMed ID: 9365848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of renal pelvic cancer with high serum level of CA 19-9].
    Iwata H; Sugimoto T; Asai T; Kamikawa S; Kim T; Hayahara N; Nakatani T; Yamamoto K; Kishimoto T
    Hinyokika Kiyo; 1998 Sep; 44(9):653-6. PubMed ID: 9805671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial Comment to Prognostic impact of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma.
    Papadopoulos GI
    Int J Urol; 2011 Jan; 18(1):48. PubMed ID: 21198936
    [No Abstract]   [Full Text] [Related]  

  • 10. [Superficial urothelial carcinoma of ureter with elevated serum CA19-9 and CEA].
    Kato S; Yasuda M; Nakano M; Ehara H; Ishihara T; Deguchi T; Sakata Y; Mori H; Shimokawa K
    Hinyokika Kiyo; 2004 Feb; 50(2):99-102. PubMed ID: 15101165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
    Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
    Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer.
    Margel D; Tal R; Baniel J
    J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG; Bai XF; Mao YL; Shao YF; Wu JX; Shan Y; Wang CF; Wang J; Tian YT; Liu Q; Xu DK; Zhao P
    Eur J Surg Oncol; 2005 Mar; 31(2):164-9. PubMed ID: 15698733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CA19.9 and CEA in transitional cell carcinoma of the bladder: serological and immunohistochemical findings.
    Hegele A; Mecklenburg V; Varga Z; Olbert P; Hofmann R; Barth P
    Anticancer Res; 2010 Dec; 30(12):5195-200. PubMed ID: 21187512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of CA19-9 as a tumor marker in urothelial malignancy.
    Chuang CK; Liao SK
    Scand J Urol Nephrol; 2004; 38(5):359-65. PubMed ID: 15764245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of CEA and CA19-9 producing recurrent transitional cell carcinoma in an Indiana pouch after total cystectomy].
    Miyoshi Y; Asakura T; Matsuzaki J; Fukuda M; Satomi Y; Akabane H
    Hinyokika Kiyo; 1996 Dec; 42(12):961-4. PubMed ID: 9013232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of both carbohydrate antigen 19-9 and duke pancreatic monoclonal antigen type 2 reflect postoperative prognosis in patients with pancreatic carcinoma.
    Shibata K; Iwaki K; Kai S; Ohta M; Kitano S
    Pancreas; 2009 Aug; 38(6):619-24. PubMed ID: 19436235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum CA19-9 levels in testicular germ cell tumor patients].
    Suzuki K; Tokue A
    Hinyokika Kiyo; 2001 Jul; 47(7):467-72. PubMed ID: 11523129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of preoperative serum CYFRA 21-1 in patients with upper urinary tract urothelial carcinoma.
    Suyama T; Nakajima K; Kanbe S; Tanaka N; Hara H; Ishii N
    Int J Urol; 2011 Jan; 18(1):43-7. PubMed ID: 21070384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor markers in staging and prognosis of colorectal carcinoma.
    Levy M; Visokai V; Lipska L; Topolcan O
    Neoplasma; 2008; 55(2):138-42. PubMed ID: 18237252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.